Yang, Hung-WeiHung-WeiYangUN-IN WUJUNG-HSIEN HSIEHHAO-CHIH TAI2021-05-262021-05-262020-0816841182https://scholars.lib.ntu.edu.tw/handle/123456789/562851enCandida albicans; Fungal pyomyositis; Upper extremity[SDGs]SDG2[SDGs]SDG3anidulafungin; cephalosporin; creatinine; fluconazole; hemoglobin; micafungin; sultamicillin; antifungal agent; abscess; adult; antifungal therapy; arm swelling; blood culture; candidemia; candidiasis; case report; clinical article; computer assisted tomography; creatinine blood level; deltoid muscle; emergency ward; erythema; Escherichia coli; fine needle aspiration biopsy; follow up; hemoglobin blood level; hepatitis B; hospital discharge; hospitalization; human; human tissue; infraspinatus muscle; Letter; leukocyte count; male; medical history; middle aged; non insulin dependent diabetes mellitus; nuclear magnetic resonance imaging; physical examination; pyomyositis; recurrent disease; shoulder disease; supraspinatus muscle; surgical debridement; treatment duration; urinary tract infection; wound care; wound closure; wound drainage; arm; Candida albicans; candidiasis; debridement; drug effect; isolation and purification; microbiology; pathology; pyomyositis; time factor; treatment outcome; Antifungal Agents; Arm; Candida albicans; Candidiasis; Debridement; Humans; Male; Middle Aged; Pyomyositis; Recurrence; Time Factors; Treatment OutcomeHow long should we treat Candida albicans pyomyositis? Insight from a cured caseletter10.1016/j.jmii.2020.02.004321071792-s2.0-85083507247https://scholars.lib.ntu.edu.tw/handle/123456789/532721